• PDF / 169,453 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 71 Downloads / 190 Views

DOWNLOAD

REPORT

---

1 S

Cardiac tamponade: case report In a single-centre observational study, which aimed at evaluating the feasibility of an uninterrupted direct oral anticoagulant (DOAC) protocol with temporary switching to dabigatran (dabigatran bridge) for atrial fibrillation ablation, a 64-year old man was described, who developed cardiac tamponade while receiving anticoagulation therapy with dabigatran etexilate. The man, who had a history of persistent atrial fibrillation, was presented for catheter ablation procedure. His oral anticoagulant therapy was temporarily switched to dabigatran etexilate 110mg twice daily [route not stated] from the day before the procedure to three days after the procedure. During the procedure, after a pulmonary vein isolation, a low blood pressure (69/50 mmHg) due to cardiac tamponade was noted. Thus, pericardiocentesis was performed and aspiration of blood was done. The man was treated with idarucizumab and protamine, and his haemodynamic parameters stabilised. The drain was removed 24 hours later, and he was discharged 7 days after the procedure. Aoyama D, et al. Feasibility of uninterrupted direct oral anticoagulants with temporary switching to Dabigatran ("Dabigatran bridge") for catheter ablation of atrial fibrillation. 803444955 International Heart Journal 60: 1315-1320, No. 6, 30 Nov 2019. Available from: URL: http://doi.org/10.1536/ihj.19-143

0114-9954/20/1786-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 11 Jan 2020 No. 1786